When the Number Says Stop

Part of Research Nurse (RN) Training: Participant Assessment and Clinical Monitoring.

About 2 minutes. Free, in your language, no account needed.

Why this matters

Most protocols contain values that mean stop. Do not dose. Hold. Withdraw.

These are the moments where a trial most depends on the nurse, because you are usually the person holding the result when it appears.

Stopping rules are absolute

A stopping rule is not a prompt to consider stopping. It is the stop.

If the rule says hold dosing when a liver enzyme exceeds a threshold, you hold. You do not weigh it against how well the participant seems. Seeming well is exactly what the rule exists to override.

The investigator may later decide to rechallenge, under whatever process the protocol defines. That is their decision, after the hold, not instead of it.

Escalate before you act, unless safety says otherwise

The usual order is: recognize, hold, tell the investigator, record.

The exception is anything urgent. If the participant needs immediate care, care comes first, and everything else follows. No protocol requires you to wait for authorization to treat somebody who is deteriorating.

Know what you are watching for

Before a visit, know the two or three values on this study that would mean stop. Not all of them. The ones that plausibly appear today.

A nurse who has to look up a stopping rule while holding an abnormal result loses minutes that matter. A nurse who already knows the number acts immediately.

In practice

A routine safety lab comes back with a potassium well outside the protocol range. The participant is sitting in front of you, cheerful, ready for their infusion.

You do not start the infusion. You tell the investigator now, not after the visit. You document the value, the time you saw it, the time you escalated, and what was decided.

Cheerful is not a laboratory value.

What this looks like when it goes wrong

A result arrives after the participant has gone home. The nurse plans to raise it at the next visit in three days.

The value met a stopping rule. The participant takes three more doses in the meantime.

Nothing in that sequence was malicious. The failure was treating an abnormal result as something to mention rather than something to act on.

Key takeaways